|Registry of biomedical companies:
[(]  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 448 active entries
400 Applewood Crescent, Unit 100
Vaughan, Ontario, L4K 0C3
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
OTAVAchemicals (est. 1997) is an international science-based chemical company that specializes in development and production of featured chemicals, bio-chemicals and bioanalytical reagents. For almost 20 years we have been providing quality products and services for pharma, biotech and R&D companies, academic institutions and government agencies.
We offer more than 250,000 compounds for high-throughput screening (HTS) including >300 target-focused libraries (Protein Kinases, Proteases, GPCRs, Ion Channels, Epigenetic Targets and others) as well as libraries of Fragments, Lead-like, Drug-like and CNS compounds. Custom library design is available on your request.
OTAVAchemicals facilities and long-standing experience make possible a variety of contract research and collaborative research projects. We already collaborate with many companies and academic institutions in Europe, US and Canada, and we hope you will consider working with us. Our team of highly skilled and talented medicinal chemists, biologists and computational chemists is ready to facilitate hit identification, hit-to-lead optimization or custom synthesis project of any level. The synthetic work could involve extensive application of cheminformatics, molecular modeling and computational chemistry techniques. Send us your compound structure now and evaluate our competitive prices and fast turn-around time.
Our compounds can now be found in the eMolecules online substructure searchable database at http://otava.emolecules.com & https://www.molport.com
OTAVAchemicals is an acknowledged leader in providing:
- Synthesis of high-quality small organic compounds for HTS, chemical building blocks and intermedieates
- Full range of custom synthesis and hit-to-lead optimization services
- Rational design of inhibitors of protein kinases and other drug targets
- Wide selection of target-focused libraries, design on request option
- Molecular modeling/computational chemistry services
- Development of novel fluorescent probes
Last update of this entry: June 09, 2020